CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

CASI Pharmaceuticals (CASIF) Debt Ratio (2023 - 2026)

Updated

CASI Pharmaceuticals' (CASIF) Debt Ratio came in at 1.01 for Q2 2026.

Analysis

CASI Pharmaceuticals (CASIF) Debt Ratio (2023 - 2026) Analysis & Trends

For FY2025, CASI Pharmaceuticals' Debt Ratio stood at 0.79, up 129.8% from FY2024.

  • In prior years, CASI Pharmaceuticals' Debt Ratio was 0.34 in FY2024 (+36.4%) and 0.25 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 CASI Pharmaceuticals 2.06 Mn -18.77 Mn - 1.01
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01
Dec 31, 2025 0.79
Dec 31, 2024 0.34
Sep 30, 2024 0.30
Jun 30, 2024 0.36
Mar 31, 2024 0.32
Dec 31, 2023 0.25
API Access

CASI Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=CASIF&period=max&api_key=YOUR_API_KEY